Immunogenicity and safety of a second dose of a measles-mumps-rubella vaccine administered to healthy participants 7 years of age or older: A phase III, randomized study.
- Resource Type
- Article
- Source
- Human Vaccines & Immunotherapeutics; 2018, Vol. 14 Issue 11, p2624-2631, 8p
- Subject
- Language
- ISSN
- 21645515